Senate to vote on stem cell research despite presidential veto threat Jaime Jansen at 9:19 AM ET
[JURIST] The US Senate continues debate Tuesday on embryonic stem cell research [JURIST news archive] funding with a vote set for Tuesday afternoon on the Stem Cell Research Enhancement Act [text; HR 810 summary] to provide government funding for stem cell research, despite a definitive statement [PDF text] from the Bush administration that President Bush will veto the bill [Washington Post report]. The administration referred to the bill as "seriously flawed," adding that "destroying nascent human life for research raises serious ethical problems, and many millions of Americans consider the practice immoral." Though the Senate is expected to garner at least 60 votes to pass the legislation, it is not clear whether the Senate will obtain at least 67 votes to override a presidential veto. The House of Representatives passed the measure last May [JURIST report], but fell short of the two-thirds majority needed to override a veto. Sen. Arlen Specter (R-PA) [official website] has sought broad Senate support [JURIST report] of the bill, while Senate Majority Leader Bill Frist (R-TN) [official website] facilitated a vote on the bill after a year of inaction.
Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible, ad-free format.